Volume 30, Number 2—February 2024
Research
Evidence of Zika Virus Reinfection by Genome Diversity and Antibody Response Analysis, Brazil
Table 1
Study visits and sample collection for participants in study of Zika virus reinfection, Brazil
Visit no. | Days after rash, range* |
---|---|
V0 | –7 to 0 |
V1 | 0–2 |
V2 | 3–4 |
V3 | 5–8 |
V4 | 9–10 |
V5 | 11–20 |
V6 | 21–30 |
V7 | 31–60 |
V8 | 61–90 |
V9 | 91–120 |
V10 | 121–150 |
V11 | 151–180 |
V12 | 181–210 |
V13 | 211–240 |
V14 | 241–270 |
V15 | 271–300 |
V16 | 301–330 |
V17 | 331–360 |
*As reported by study participants.
1These authors contributed equally to this article.
Page created: January 09, 2024
Page updated: January 24, 2024
Page reviewed: January 24, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.